Phase 3 Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with dry age-related macular degeneration (AMD) with at least one large deposit (called a drusen) in your eye, larger than a specific size (125 microns) as defined by a major eye health study.
- You are able to undergo certain eye imaging and vision tests, including two types of eye scans (OCT and OCT angiography) and a standard vision test.
- You are between 50 and 85 years old.
- You have previously taken blood-thinning medications known as antiplatelet drugs (such as aspirin or clopidogrel).
Who may not be able to join:
- You have an advanced form of AMD, such as geographic atrophy (significant loss of cells in the back of the eye) or abnormal blood vessel growth in the eye (choroidal neovascularization).
- You have another eye condition affecting your vision, such as a detached retina or diabetes-related swelling in the eye (diabetic macular edema).
- You have previously had injections into the eye (anti-VEGF injections) or laser treatment on the central part of your eye (macula).
- You are currently taking certain medications, including antidepressants (SSRIs or SNRIs), antifungal medications (azoles), anti-inflammatory drugs (NSAIDs), two antiplatelet drugs at the same time, or blood thinners (anticoagulants).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +66851283362
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Drusen volume analysis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.